This open-label, prospective, observational study will evaluate the clinical response to etanercept + methotrexate therapy in patients with moderate to severe rheumatoid arthritis, as prescribed by the rheumatologist in a normal clinical setting in Greece
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01558089?cond=%22Arthritis%22&lup_s=08/23/2013&lup_d=30
